Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	FAT4 ENPP1 PCDHGA4 PCDHB5 PCDH11Y PCDHB13 PCDHB9 PCDHB8 FSCB PCDHB18P FAT1 FAT2 CELSR2 SYT8 VCAN PCDH11X PCDH1 CDH4 OC90 ATP5F1B	2.44e-06	749	160	20	GO:0005509
GeneOntologyMolecularFunction	granulocyte colony-stimulating factor receptor binding	CEACAM5 CEACAM6 CEACAM1	1.72e-04	14	160	3	GO:0005130
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	FAT4 CEACAM5 PCDHGA4 PCDHB5 PCDH11Y PCDHB13 PCDHB9 PCDHB8 CEACAM6 CEACAM1 PCDHB18P FAT1 FAT2 CELSR2 PCDH11X PCDH1 CDH4	1.01e-13	187	160	17	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	FAT4 CEACAM5 PCDHGA4 PCDHB5 PCDH11Y PCDHB13 PCDHB9 PCDHB8 CEACAM6 CEACAM1 PCDHB18P TGFBR2 FAT1 FAT2 CELSR2 PCDH11X PCDH1 CDH4	4.38e-11	313	160	18	GO:0098742
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated cytotoxicity directed against tumor cell target	CEACAM5 CEACAM6 CEACAM1 KLRK1 CD226	7.93e-07	23	160	5	GO:0002858
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated immune response to tumor cell	CEACAM5 CEACAM6 CEACAM1 KLRK1 CD226	9.95e-07	24	160	5	GO:0002855
GeneOntologyBiologicalProcess	natural killer cell mediated cytotoxicity directed against tumor cell target	CEACAM5 CEACAM6 CEACAM1 KLRK1 CD226	9.95e-07	24	160	5	GO:0002420
GeneOntologyBiologicalProcess	natural killer cell mediated immune response to tumor cell	CEACAM5 CEACAM6 CEACAM1 KLRK1 CD226	1.24e-06	25	160	5	GO:0002423
GeneOntologyBiologicalProcess	cell-cell adhesion	DPP4 SEMA4D FAT4 RAP1GAP CEACAM5 PCDHGA4 PCDHB5 PCDH11Y PCDHB13 PCDHB9 PCDHB8 CEACAM6 CEACAM1 KLRK1 PCDHB18P TGFBR2 FAT1 FAT2 CELSR2 CTNNA3 PCDH11X LRRC7 PCDH1 CDH4	3.00e-06	1077	160	24	GO:0098609
GeneOntologyBiologicalProcess	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	PCDHB5 PCDHB13 PCDHB9 PCDHB8 PCDH1 CDH4	3.37e-06	53	160	6	GO:0016339
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated immunity	DPP4 CEACAM5 CEACAM6 CEACAM1 KLRK1 CD226	3.71e-05	80	160	6	GO:0002715
GeneOntologyBiologicalProcess	vasculogenesis	CEACAM5 ENPP1 NTRK2 CEACAM6 CEACAM1 TGFBR2 PTPRJ	3.80e-05	118	160	7	GO:0001570
GeneOntologyBiologicalProcess	regulation of immune response to tumor cell	CEACAM5 CEACAM6 CEACAM1 KLRK1 CD226	3.82e-05	49	160	5	GO:0002837
GeneOntologyBiologicalProcess	regulation of response to tumor cell	CEACAM5 CEACAM6 CEACAM1 KLRK1 CD226	4.22e-05	50	160	5	GO:0002834
GeneOntologyBiologicalProcess	immune response to tumor cell	CEACAM5 CEACAM6 CEACAM1 KLRK1 CD226	7.32e-05	56	160	5	GO:0002418
GeneOntologyBiologicalProcess	regulation of phosphorus metabolic process	SEMA4D CEACAM5 VRK3 ENPP1 NTRK2 ROR2 CEACAM6 PPP1R14D SMG5 STIL PARP14 CCNY CEACAM1 TGFBR2 CCNYL1 PTPRB PTPRJ PROM2 VCAN AGT CCNA1 C3 ADGRF5 ROS1 GMPPA	1.01e-04	1423	160	25	GO:0051174
GeneOntologyBiologicalProcess	negative regulation of vascular permeability	CEACAM5 CEACAM6 CEACAM1 PTPRJ	1.35e-04	34	160	4	GO:0043116
GeneOntologyBiologicalProcess	synapse assembly	DOCK1 SEMA4D NTRK2 PCDHB5 PCDHB13 PCDHB9 ADGRB2 PCDHB8 ARHGEF9 SLITRK6	1.51e-04	308	160	10	GO:0007416
GeneOntologyBiologicalProcess	negative regulation of brown fat cell proliferation	CEACAM5 CEACAM6 CEACAM1	1.57e-04	14	160	3	GO:0070348
GeneOntologyBiologicalProcess	positive regulation of phosphorus metabolic process	SEMA4D CEACAM5 VRK3 NTRK2 ROR2 CEACAM6 PPP1R14D STIL PARP14 CCNY CEACAM1 TGFBR2 PTPRJ PROM2 AGT C3 ADGRF5 ROS1	1.67e-04	879	160	18	GO:0010562
GeneOntologyBiologicalProcess	positive regulation of phosphate metabolic process	SEMA4D CEACAM5 VRK3 NTRK2 ROR2 CEACAM6 PPP1R14D STIL PARP14 CCNY CEACAM1 TGFBR2 PTPRJ PROM2 AGT C3 ADGRF5 ROS1	1.67e-04	879	160	18	GO:0045937
GeneOntologyBiologicalProcess	negative regulation of protein modification process	SEMA4D CEACAM5 ENPP1 CEACAM6 PPP1R14D PARP14 FSCB CEACAM1 PTPRB PTPRJ AGT MINAR1 CRTAP	1.85e-04	512	160	13	GO:0031400
GeneOntologyBiologicalProcess	regulation of brown fat cell proliferation	CEACAM5 CEACAM6 CEACAM1	1.95e-04	15	160	3	GO:0070347
GeneOntologyBiologicalProcess	negative regulation of natural killer cell mediated immune response to tumor cell	CEACAM5 CEACAM6 CEACAM1	1.95e-04	15	160	3	GO:0002856
GeneOntologyBiologicalProcess	negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target	CEACAM5 CEACAM6 CEACAM1	1.95e-04	15	160	3	GO:0002859
GeneOntologyBiologicalProcess	positive regulation of homophilic cell adhesion	CEACAM5 CEACAM6 CEACAM1	1.95e-04	15	160	3	GO:1903387
GeneOntologyBiologicalProcess	cell junction organization	DOCK1 SEMA4D CEACAM5 NTRK2 PCDHB5 ROR2 PCDHB13 PCDHB9 ADGRB2 PCDHB8 CEACAM6 ARHGAP39 CEACAM1 PTPRJ AGT ARHGEF9 C3 SLITRK6 CDH4	2.03e-04	974	160	19	GO:0034330
GeneOntologyBiologicalProcess	natural killer cell mediated immunity	DPP4 CEACAM5 CEACAM6 CEACAM1 KLRK1 CD226	2.08e-04	109	160	6	GO:0002228
GeneOntologyBiologicalProcess	response to tumor cell	CEACAM5 CEACAM6 CEACAM1 KLRK1 CD226	2.27e-04	71	160	5	GO:0002347
GeneOntologyBiologicalProcess	insulin receptor internalization	CEACAM5 CEACAM6 CEACAM1	2.38e-04	16	160	3	GO:0038016
GeneOntologyBiologicalProcess	regulation of phosphate metabolic process	SEMA4D CEACAM5 VRK3 ENPP1 NTRK2 ROR2 CEACAM6 PPP1R14D SMG5 STIL PARP14 CCNY CEACAM1 TGFBR2 CCNYL1 PTPRB PTPRJ PROM2 VCAN AGT CCNA1 C3 ADGRF5 ROS1	2.55e-04	1421	160	24	GO:0019220
GeneOntologyBiologicalProcess	brown fat cell proliferation	CEACAM5 CEACAM6 CEACAM1	2.88e-04	17	160	3	GO:0070342
GeneOntologyBiologicalProcess	insulin catabolic process	CEACAM5 CEACAM6 CEACAM1	2.88e-04	17	160	3	GO:1901143
GeneOntologyBiologicalProcess	granulocyte colony-stimulating factor signaling pathway	CEACAM5 CEACAM6 CEACAM1	2.88e-04	17	160	3	GO:0038158
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated cytotoxicity	CEACAM5 CEACAM6 CEACAM1 KLRK1 CD226	3.13e-04	76	160	5	GO:0042269
GeneOntologyBiologicalProcess	regulation of homophilic cell adhesion	CEACAM5 CEACAM6 CEACAM1	3.43e-04	18	160	3	GO:1903385
GeneOntologyBiologicalProcess	negative regulation of anoikis	CEACAM5 NTRK2 CEACAM6	4.05e-04	19	160	3	GO:2000811
GeneOntologyBiologicalProcess	negative regulation of hepatocyte proliferation	CEACAM5 CEACAM6 CEACAM1	4.74e-04	20	160	3	GO:2000346
GeneOntologyBiologicalProcess	negative regulation of tissue remodeling	CEACAM5 CEACAM6 CEACAM1 AGT	4.80e-04	47	160	4	GO:0034104
GeneOntologyBiologicalProcess	regulation of protein modification process	SEMA4D CEACAM5 VRK3 ENPP1 NTRK2 CEACAM6 PPP1R14D COPS3 STIL PARP14 FSCB CCNY CEACAM1 TGFBR2 CCNYL1 PTPRB PTPRJ PROM2 VCAN AGT CCNA1 C3 MINAR1 CRTAP	4.98e-04	1488	160	24	GO:0031399
GeneOntologyBiologicalProcess	cell junction assembly	DOCK1 SEMA4D NTRK2 PCDHB5 PCDHB13 PCDHB9 ADGRB2 PCDHB8 PTPRJ AGT ARHGEF9 SLITRK6 CDH4	5.09e-04	569	160	13	GO:0034329
GeneOntologyBiologicalProcess	negative regulation of fat cell proliferation	CEACAM5 CEACAM6 CEACAM1	5.50e-04	21	160	3	GO:0070345
GeneOntologyBiologicalProcess	negative regulation of response to tumor cell	CEACAM5 CEACAM6 CEACAM1	5.50e-04	21	160	3	GO:0002835
GeneOntologyBiologicalProcess	negative regulation of immune response to tumor cell	CEACAM5 CEACAM6 CEACAM1	5.50e-04	21	160	3	GO:0002838
GeneOntologyBiologicalProcess	regulation of epidermal growth factor receptor signaling pathway	CEACAM5 CEACAM6 CEACAM1 PTPRJ AGT	5.54e-04	86	160	5	GO:0042058
GeneOntologyBiologicalProcess	blood vessel morphogenesis	CEACAM5 ENPP1 NTRK2 ADGRB2 CEACAM6 APOB CEACAM1 TGFBR2 PTPRB PTPRJ NFE2L2 AGT C3 ADGRF5 MINAR1 ATP5F1B	6.32e-04	817	160	16	GO:0048514
GeneOntologyBiologicalProcess	negative regulation of granulocyte differentiation	CEACAM5 CEACAM6 CEACAM1	6.33e-04	22	160	3	GO:0030853
GeneOntologyBiologicalProcess	positive regulation of cell junction assembly	SEMA4D NTRK2 ADGRB2 PTPRJ AGT SLITRK6	6.80e-04	136	160	6	GO:1901890
GeneOntologyBiologicalProcess	negative regulation of platelet aggregation	CEACAM5 CEACAM6 CEACAM1	7.24e-04	23	160	3	GO:0090331
GeneOntologyCellularComponent	transforming growth factor beta ligand-receptor complex	CEACAM5 CEACAM6 CEACAM1 TGFBR2	5.74e-06	16	161	4	GO:0070021
GeneOntologyCellularComponent	cell-cell junction	MPP1 DPP4 CEACAM5 PCDHB5 CEACAM6 CEACAM1 FAT1 FAT2 UBA1 PTPRJ MLC1 CTNNA3 LRRC7 DNMBP PCDH1 CDH4	1.39e-05	591	161	16	GO:0005911
GeneOntologyCellularComponent	cell surface	CACNA1C DPP4 CEACAM5 ENPP1 NTRK2 ROR2 MUC16 CEACAM6 CEACAM1 KLRK1 TGFBR2 ANOS1 PTPRJ CD226 PROM2 VCAN CLPTM1 C3 ADGRF5 ROS1 SLITRK6 ATP5F1B	4.46e-05	1111	161	22	GO:0009986
GeneOntologyCellularComponent	vacuolar lumen	APOB PRELP TPP1 VCAN C3 MNDA DYNC1H1	4.68e-04	178	161	7	GO:0005775
GeneOntologyCellularComponent	anchoring junction	MPP1 DPP4 CEACAM5 HYOU1 PCDHB5 CEACAM6 CEACAM1 FAT1 FAT2 UBA1 PTPRJ MLC1 CTNNA3 LRRC7 DNMBP PCDH1 CDH4 TM4SF20	5.40e-04	976	161	18	GO:0070161
GeneOntologyCellularComponent	lysosome	DPP4 ENPP1 WDR81 CEACAM6 APOB UBA1 NEU2 STS MLC1 PRELP TPP1 VCAN C3 MNDA DYNC1H1 VPS13B	5.42e-04	811	161	16	GO:0005764
GeneOntologyCellularComponent	lytic vacuole	DPP4 ENPP1 WDR81 CEACAM6 APOB UBA1 NEU2 STS MLC1 PRELP TPP1 VCAN C3 MNDA DYNC1H1 VPS13B	5.42e-04	811	161	16	GO:0000323
MousePheno	decreased susceptibility to Coronaviridae infection	DPP4 CEACAM5 CEACAM6 CEACAM1 C3	5.53e-06	28	131	5	MP:0020950
MousePheno	decreased susceptibility to Coronaviridae infection induced morbidity/mortality	DPP4 CEACAM5 CEACAM6 CEACAM1	1.59e-05	17	131	4	MP:0031047
Domain	CA	FAT4 PCDHGA4 PCDHB5 PCDH11Y PCDHB13 PCDHB9 PCDHB8 FREM2 FAT1 FAT2 CELSR2 PCDH11X PCDH1 CDH4	8.38e-13	115	157	14	SM00112
Domain	Cadherin	FAT4 PCDHGA4 PCDHB5 PCDH11Y PCDHB13 PCDHB9 PCDHB8 FREM2 FAT1 FAT2 CELSR2 PCDH11X PCDH1 CDH4	1.20e-12	118	157	14	IPR002126
Domain	Cadherin_CS	FAT4 PCDHGA4 PCDHB5 PCDH11Y PCDHB13 PCDHB9 PCDHB8 FAT1 FAT2 CELSR2 PCDH11X PCDH1 CDH4	7.39e-12	109	157	13	IPR020894
Domain	CADHERIN_1	FAT4 PCDHGA4 PCDHB5 PCDH11Y PCDHB13 PCDHB9 PCDHB8 FAT1 FAT2 CELSR2 PCDH11X PCDH1 CDH4	1.18e-11	113	157	13	PS00232
Domain	Cadherin	FAT4 PCDHGA4 PCDHB5 PCDH11Y PCDHB13 PCDHB9 PCDHB8 FAT1 FAT2 CELSR2 PCDH11X PCDH1 CDH4	1.18e-11	113	157	13	PF00028
Domain	CADHERIN_2	FAT4 PCDHGA4 PCDHB5 PCDH11Y PCDHB13 PCDHB9 PCDHB8 FAT1 FAT2 CELSR2 PCDH11X PCDH1 CDH4	1.32e-11	114	157	13	PS50268
Domain	-	FAT4 PCDHGA4 PCDHB5 PCDH11Y PCDHB13 PCDHB9 PCDHB8 FAT1 FAT2 CELSR2 PCDH11X PCDH1 CDH4	1.32e-11	114	157	13	2.60.40.60
Domain	Cadherin-like	FAT4 PCDHGA4 PCDHB5 PCDH11Y PCDHB13 PCDHB9 PCDHB8 FAT1 FAT2 CELSR2 PCDH11X PCDH1 CDH4	1.65e-11	116	157	13	IPR015919
Domain	Cadherin_2	PCDHGA4 PCDHB5 PCDH11Y PCDHB13 PCDHB9 PCDHB8 PCDH11X PCDH1	7.01e-08	65	157	8	PF08266
Domain	Cadherin_N	PCDHGA4 PCDHB5 PCDH11Y PCDHB13 PCDHB9 PCDHB8 PCDH11X PCDH1	7.01e-08	65	157	8	IPR013164
Domain	Protocadherin	PCDH11Y PCDH11X PCDH1	5.76e-06	5	157	3	PF08374
Domain	Protocadherin	PCDH11Y PCDH11X PCDH1	5.76e-06	5	157	3	IPR013585
Domain	LAM_G_DOMAIN	FAT4 COL24A1 FAT1 FAT2 CELSR2	1.58e-05	38	157	5	PS50025
Domain	Laminin_G_2	FAT4 COL24A1 FAT1 FAT2 CELSR2	2.04e-05	40	157	5	PF02210
Domain	Cadherin_C	PCDHGA4 PCDHB5 PCDHB13 PCDHB9 PCDHB8	2.61e-05	42	157	5	IPR032455
Domain	Cadherin_C_2	PCDHGA4 PCDHB5 PCDHB13 PCDHB9 PCDHB8	2.61e-05	42	157	5	PF16492
Domain	Cyclin_Y	CCNY CCNYL1	7.02e-05	2	157	2	IPR012399
Domain	Laminin_G	FAT4 COL24A1 FAT1 FAT2 CELSR2	1.26e-04	58	157	5	IPR001791
Domain	LamG	FAT4 FAT1 FAT2 CELSR2	5.02e-04	44	157	4	SM00282
Domain	IGc2	SEMA4D CEACAM5 NTRK2 ROR2 CEACAM6 CEACAM1 CD226 ADGRF5	8.54e-04	235	157	8	SM00408
Domain	Ig_sub2	SEMA4D CEACAM5 NTRK2 ROR2 CEACAM6 CEACAM1 CD226 ADGRF5	8.54e-04	235	157	8	IPR003598
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGA4 PCDHB5 PCDH11Y PCDHB13 PCDHB9 PCDHB8 PCDHB18P FAT2 CELSR2 PCDH11X PCDH1	9.33e-14	77	164	11	10835267
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGA4 PCDHB5 PCDH11Y PCDHB13 PCDHB9 PCDHB8 PCDHB18P FAT2 CELSR2 PCDH11X PCDH1	1.44e-13	80	164	11	10716726
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHGA4 PCDHB5 PCDH11Y PCDHB13 PCDHB9 PCDHB8 PCDHB18P PCDH11X PCDH1	7.86e-11	74	164	9	10817752
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGA4 PCDHB5 PCDHB13 PCDHB9 PCDHB8 PCDHB18P FAT2 CELSR2	1.91e-09	72	164	8	10380929
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	DPP4 HYOU1 NTRK2 APOB CEACAM1 FREM2 FAT2 PTPRJ AGT C3 ADGRF5 C7	3.98e-09	257	164	12	16335952
Pubmed	Reduction of Nipbl impairs cohesin loading locally and affects transcription but not cohesion-dependent functions in a mouse model of Cornelia de Lange Syndrome.	PCDH11Y PCDHB13 PCDHB8 PCDHB18P PCDH11X	2.42e-08	19	164	5	23920377
Pubmed	The human and murine protocadherin-beta one-exon gene families show high evolutionary conservation, despite the difference in gene number.	PCDHB5 PCDHB13 PCDHB9 PCDHB8 PCDHB18P	3.21e-08	20	164	5	11322959
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	DOCK1 RAP1GAP CEACAM5 HYOU1 VRK3 PCDHB5 COPS3 CREM SPICE1 PPP2R2B FAT1 MDN1 SYT8 SLC50A1 NFE2L2 TPP1 VCAN ARHGEF9 CTNNA3 C3 GMPPA TM4SF20 HYDIN	4.83e-08	1293	164	23	15342556
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	MPP1 ARFGEF1 APOB PARP14 CCNY FAT1 CCNYL1 CELSR2 PTPRJ PROM2 PCDH11X SLITRK6 VPS51 PCDH1 VPS13B	9.45e-08	569	164	15	30639242
Pubmed	Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer.	CEACAM5 CEACAM6 CEACAM1	1.03e-07	3	164	3	25409014
Pubmed	Expression of Chosen Carcinoembryonic-Related Cell Adhesion Molecules in Pancreatic Intraepithelial Neoplasia (PanIN) Associated with Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma (PDAC).	CEACAM5 CEACAM6 CEACAM1	1.03e-07	3	164	3	31171910
Pubmed	delta-Protocadherins: a gene family expressed differentially in the mouse brain.	PCDH11Y PCDH11X PCDH1 CDH4	1.53e-07	11	164	4	15905963
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	FAT4 FRAS1 HYOU1 ENPP1 ROR2 ARFGEF1 RTN3 ATP9A MBOAT2 ELAC2 FAT1 UBA1 STS CELSR2 PTPRJ AGT CLPTM1 TXNDC16 ATP5F1B CRTAP TANGO6	2.59e-07	1201	164	21	35696571
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHGA4 PCDHB5 PCDHB13 PCDHB9 PCDHB8 PCDHB18P	2.98e-07	57	164	6	32633719
Pubmed	Protocadherins.	PCDHB5 PCDHB13 PCDHB9 PCDHB8	3.30e-07	13	164	4	12231349
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHGA4 PCDHB5 PCDHB13 PCDHB9 PCDHB8 PCDHB18P	3.31e-07	58	164	6	30377227
Pubmed	Diverse oligomeric states of CEACAM IgV domains.	CEACAM5 CEACAM6 CEACAM1	4.10e-07	4	164	3	26483485
Pubmed	Four carcinoembryonic antigen subfamily members, CEA, NCA, BGP and CGM2, selectively expressed in the normal human colonic epithelium, are integral components of the fuzzy coat.	CEACAM5 CEACAM6 CEACAM1	4.10e-07	4	164	3	10436421
Pubmed	Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs.	CEACAM5 CEACAM6 CEACAM1	4.10e-07	4	164	3	27748768
Pubmed	Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA.	CEACAM5 CEACAM6 CEACAM1	4.10e-07	4	164	3	27748756
Pubmed	CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells.	CEACAM5 CEACAM6 CEACAM1 KLRK1	6.25e-07	15	164	4	22143889
Pubmed	CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling.	CEACAM5 CEACAM6 CEACAM1 KLRK1	8.30e-07	16	164	4	23696226
Pubmed	Regulation of the epithelial adhesion molecule CEACAM1 is important for palate formation.	CEACAM5 CEACAM6 CEACAM1 TGFBR2	8.30e-07	16	164	4	23613893
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGA4 PCDHB5 PCDHB13 PCDHB9 PCDHB8 PCDHB18P	8.62e-07	68	164	6	11230163
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	DPP4 FAT4 CEACAM5 APOB IL18BP PGM1 CEACAM1 FREM2 UBA1 PTPRJ PROM2 TPP1 AGT C3 C7 GMPPA DYNC1H1 ATP5F1B	3.39e-06	1070	164	18	23533145
Pubmed	Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.	FAT4 FAT1 FAT2	3.55e-06	7	164	3	16059920
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RAP1GAP ARHGAP39 ATP8B2 METTL13 FAT2 IPO9 TXNDC16 UBR3 ADGRF5 MINAR1 NUP160 TANGO6	4.31e-06	493	164	12	15368895
Pubmed	Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).	DPP4 HYOU1 MUC16 CEACAM1 FAT2 UBA1 PROM2 PRELP TXNDC16 DYNC1H1 ATP5F1B	5.14e-06	417	164	11	19199708
Pubmed	A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome.	DOCK1 CEACAM5 WDR81 CEACAM6 APOB CEACAM1 ANOS1 UBR3	6.32e-06	205	164	8	12040188
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	HYOU1 PPP2R2B UBA1 IPO9 MDN1 CLPTM1 EIF3K UBR3 C3 UQCRC1 GMPPA DYNC1H1 ATP5F1B	1.34e-05	647	164	13	26618866
Pubmed	Carcinoembryonic antigen (CEA)-related cell adhesion molecules are co-expressed in the human lung and their expression can be modulated in bronchial epithelial cells by non-typable Haemophilus influenzae, Moraxella catarrhalis, TLR3, and type I and II interferons.	CEACAM5 CEACAM6	2.21e-05	2	164	2	23941132
Pubmed	Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder.	CEACAM5 MUC16	2.21e-05	2	164	2	24680660
Pubmed	NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.	KLRK1 CD226	2.21e-05	2	164	2	18657862
Pubmed	Identification of two novel CAKUT-causing genes by massively parallel exon resequencing of candidate genes in patients with unilateral renal agenesis.	FRAS1 FREM2	2.21e-05	2	164	2	21900877
Pubmed	Bacterial protein domains with a novel Ig-like fold target human CEACAM receptors.	CEACAM5 CEACAM1	2.21e-05	2	164	2	33522633
Pubmed	Conservation of PCDHX in mammals; expression of human X/Y genes predominantly in brain.	PCDH11Y PCDH11X	2.21e-05	2	164	2	11003707
Pubmed	Pcdh11x Negatively Regulates Dendritic Branching.	PCDH11Y PCDH11X	2.21e-05	2	164	2	25687328
Pubmed	Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.	CEACAM5 CEACAM6	2.21e-05	2	164	2	17201906
Pubmed	Differential recognition of members of the carcinoembryonic antigen family by Afa/Dr adhesins of diffusely adhering Escherichia coli (Afa/Dr DAEC).	CEACAM5 CEACAM6	2.21e-05	2	164	2	15130118
Pubmed	Expression of complementary DNA and genomic clones for carcinoembryonic antigen and nonspecific cross-reacting antigen in Chinese hamster ovary and mouse fibroblast cells and characterization of the membrane-expressed products.	CEACAM5 CEACAM6	2.21e-05	2	164	2	2317824
Pubmed	Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions.	CEACAM5 CEACAM1	2.21e-05	2	164	2	19461083
Pubmed	SorCS2 is required for BDNF-dependent plasticity in the hippocampus.	NTRK2 SORCS2	2.21e-05	2	164	2	27457814
Pubmed	Expression of tyrosine kinase receptor B in eutopic endometrium of women with adenomyosis.	NTRK2 MUC16	2.21e-05	2	164	2	21079983
Pubmed	Differential expression of carcinoembryonic antigen-related cell adhesion molecule-5 (CEACAM5) and dipeptidyl peptidase-4 (DPP4) with detection of Middle East respiratory syndrome-coronavirus in peripheral blood.	DPP4 CEACAM5	2.21e-05	2	164	2	36279687
Pubmed	Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study.	CEACAM5 MUC16	2.21e-05	2	164	2	34801967
Pubmed	Carcinoembryonic antigen family: characterization of cDNAs coding for NCA and CEA and suggestion of nonrandom sequence variation in their conserved loop-domains.	CEACAM5 CEACAM6	2.21e-05	2	164	2	3220478
Pubmed	Haplotypic diversity in human CEACAM genes: effects on susceptibility to meningococcal disease.	CEACAM6 CEACAM1	2.21e-05	2	164	2	17960155
Pubmed	T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction.	CEACAM6 CEACAM1	2.21e-05	2	164	2	35141051
Pubmed	Molecular study of 33 families with Fraser syndrome new data and mutation review.	FRAS1 FREM2	2.21e-05	2	164	2	18671281
Pubmed	Cadherin expression delineates the divisions of the postnatal and adult mouse amygdala.	PCDH11Y PCDH11X	2.21e-05	2	164	2	22592879
Pubmed	CD66 identifies the biliary glycoprotein (BGP) adhesion molecule: cloning, expression, and adhesion functions of the BGPc splice variant.	CEACAM6 CEACAM1	2.21e-05	2	164	2	8018919
Pubmed	Novel loss of function variants in FRAS1 AND FREM2 underlie renal agenesis in consanguineous families.	FRAS1 FREM2	2.21e-05	2	164	2	32643034
Pubmed	Protocadherin X ( PCDHX) and Y ( PCDHY) genes; multiple mRNA isoforms encoding variant signal peptides and cytoplasmic domains.	PCDH11Y PCDH11X	2.21e-05	2	164	2	14727141
Pubmed	Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.	KLRK1 CD226	2.21e-05	2	164	2	32082316
Pubmed	Lack of association between protocadherin 11-X/Y (PCDH11X and PCDH11Y) polymorphisms and late onset Alzheimer's disease.	PCDH11Y PCDH11X	2.21e-05	2	164	2	21276771
Pubmed	Expression of CEACAM1 or CEACAM5 in AZ-521 cells restores the type IV secretion deficiency for translocation of CagA by Helicobacter pylori.	CEACAM5 CEACAM1	2.21e-05	2	164	2	30321907
Pubmed	Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells.	KLRK1 CD226	2.21e-05	2	164	2	25854581
Pubmed	Phenotypic screen of sixty-eight colorectal cancer cell lines identifies CEACAM6 and CEACAM5 as markers of acid resistance.	CEACAM5 CEACAM6	2.21e-05	2	164	2	38502695
Pubmed	Accelerated evolution of Protocadherin11X/Y: a candidate gene-pair for cerebral asymmetry and language.	PCDH11Y PCDH11X	2.21e-05	2	164	2	16874762
Pubmed	PCDH11 is X/Y homologous in Homo sapiens but not in Gorilla gorilla and Pan troglodytes.	PCDH11Y PCDH11X	2.21e-05	2	164	2	16825765
Pubmed	Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation.	DPP4 NFE2L2	2.21e-05	2	164	2	26187356
Pubmed	The protocadherin 11X/Y (PCDH11X/Y) gene pair as determinant of cerebral asymmetry in modern Homo sapiens.	PCDH11Y PCDH11X	2.21e-05	2	164	2	23600975
Pubmed	Binding of Candida albicans to Human CEACAM1 and CEACAM6 Modulates the Inflammatory Response of Intestinal Epithelial Cells.	CEACAM6 CEACAM1	2.21e-05	2	164	2	28292985
Pubmed	A comparative analysis of the pig, mouse, and human PCDHX genes.	PCDH11Y PCDH11X	2.21e-05	2	164	2	15112107
Pubmed	Ichthyosis and Kallmann syndrome: not always a contiguous gene syndrome.	ANOS1 STS	2.21e-05	2	164	2	25726327
Pubmed	Cell adhesion activity of non-specific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface: homophilic and heterophilic adhesion.	CEACAM5 CEACAM6	2.21e-05	2	164	2	2803308
Pubmed	CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells.	CEACAM6 CEACAM1	2.21e-05	2	164	2	16115956
Pubmed	Protocadherin 11X/Y a human-specific gene pair: an immunohistochemical survey of fetal and adult brains.	PCDH11Y PCDH11X	2.21e-05	2	164	2	22744706
Pubmed	Specific Binding to Differentially Expressed Human Carcinoembryonic Antigen-Related Cell Adhesion Molecules Determines the Outcome of Neisseria gonorrhoeae Infections along the Female Reproductive Tract.	CEACAM5 CEACAM1	2.21e-05	2	164	2	29760215
Pubmed	Role of human natural killer cells during Epstein-Barr virus infection.	KLRK1 CD226	2.21e-05	2	164	2	25597312
Pubmed	Human carcinoembryonic antigen functions as a general inhibitor of anoikis.	CEACAM5 CEACAM6	2.21e-05	2	164	2	10910050
Pubmed	Role of complement 3a in the synthetic phenotype and angiotensin II-production in vascular smooth muscle cells from spontaneously hypertensive rats.	AGT C3	2.21e-05	2	164	2	22089112
Pubmed	Quantitative analysis of alternative transcripts of human PCDH11X/Y genes.	PCDH11Y PCDH11X	2.21e-05	2	164	2	19859901
Pubmed	Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment.	APOB AGT	2.21e-05	2	164	2	15614026
Pubmed	Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin.	CEACAM5 MUC16	2.21e-05	2	164	2	22941175
Pubmed	Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1.	CEACAM5 CEACAM1	2.21e-05	2	164	2	15905509
Pubmed	Interleukin-18 binding protein attenuates lipopolysaccharide-induced acute lung injury in mice via suppression NF-κB and activation Nrf2 pathway.	IL18BP NFE2L2	2.21e-05	2	164	2	30301527
Pubmed	Differential expression of ligands for NKG2D and DNAM-1 receptors by epithelial ovarian cancer-derived exosomes and its influence on NK cell cytotoxicity.	KLRK1 CD226	2.21e-05	2	164	2	26563374
Pubmed	Densin-180 Controls the Trafficking and Signaling of L-Type Voltage-Gated Cav1.2 Ca2+ Channels at Excitatory Synapses.	CACNA1C LRRC7	2.21e-05	2	164	2	28363979
Pubmed	Isoliquiritigenin alleviated the Ang II-induced hypertensive renal injury through suppressing inflammation cytokines and oxidative stress-induced apoptosis via Nrf2 and NF-κB pathways.	NFE2L2 AGT	2.21e-05	2	164	2	30340829
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DOCK1 CACNA1C SEMA4D TM7SF3 ROR2 PCDH11Y RTN3 ARHGAP39 CCNY FBXO16 NADSYN1 PTPRB PTPRJ SYNJ2 PROM2 ARHGEF9 LRRC7 UQCRC1 PCDH1 VPS13B	2.58e-05	1489	164	20	28611215
Pubmed	A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	1985902
Pubmed	CEACAM1+ myeloid cells control angiogenesis in inflammation.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	19273835
Pubmed	Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	16638824
Pubmed	Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	20044046
Pubmed	Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	32150576
Pubmed	Mouse hepatitis virus type 4 (JHM strains). induced fatal central nervous system disease. I. genetic control and murine neuron as the susceptible site of disease.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	6265583
Pubmed	Insulin Sensitivity Is Retained in Mice with Endothelial Loss of Carcinoembryonic Antigen Cell Adhesion Molecule 1.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	34440862
Pubmed	CEACAM1 is a potent regulator of B cell receptor complex-induced activation.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	12832451
Pubmed	CEACAM1 confers resistance toward oxygen-induced vessel damage in a mouse model of retinopathy of prematurity.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	25406283
Pubmed	Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	21670291
Pubmed	Investigations on the usefulness of CEACAMs as potential imaging targets for molecular imaging purposes.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	22162753
Pubmed	A mouse analogue of the human carcinoembryonic antigen.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	2702644
Pubmed	Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	8380065
Pubmed	The receptor for mouse hepatitis virus in the resistant mouse strain SJL is functional: implications for the requirement of a second factor for viral infection.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	1279194
Pubmed	Exogenous carcinoembryonic antigen-related cell adhesion molecule 1 suppresses 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in mice.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	25724769
Pubmed	High-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletion.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	26374765
Pubmed	CEACAM1 deficiency delays important wound healing processes.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	22092845
Pubmed	Activation-induced expression of carcinoembryonic antigen-cell adhesion molecule 1 regulates mouse T lymphocyte function.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	11801635
Pubmed	Liver-specific reconstitution of CEACAM1 reverses the metabolic abnormalities caused by its global deletion in male mice.	CEACAM5 CEACAM6 CEACAM1	2.84e-05	13	164	3	28913658
Interaction	NXPH2 interactions	FAT4 FRAS1 FREM2 FAT1 CELSR2 PCDH1	2.36e-07	33	163	6	int:NXPH2
Interaction	CMA1 interactions	FAT4 FRAS1 FREM2 FAT1 CELSR2 AGT	1.83e-06	46	163	6	int:CMA1
Interaction	DCANP1 interactions	FAT4 FREM2 FAT1 CELSR2	1.45e-05	19	163	4	int:DCANP1
Interaction	XAGE1A interactions	FAT4 FRAS1 FREM2 FAT1 CELSR2	1.93e-05	41	163	5	int:XAGE1A
Interaction	PSG8 interactions	FAT4 FRAS1 FREM2 FAT1 CELSR2	1.93e-05	41	163	5	int:PSG8
Interaction	C2CD4B interactions	FAT4 FRAS1 FREM2 FAT1 CELSR2	2.74e-05	44	163	5	int:C2CD4B
Interaction	DKKL1 interactions	FAT4 FRAS1 FREM2 FAT1 MDN1 CELSR2 PCDH1	3.34e-05	111	163	7	int:DKKL1
Interaction	CEACAM8 interactions	FAT4 FRAS1 CEACAM6 CEACAM1 FREM2 FAT1 TXNDC16	5.22e-05	119	163	7	int:CEACAM8
Interaction	IFNE interactions	FAT4 FRAS1 FAT1 PCDH1	6.26e-05	27	163	4	int:IFNE
Cytoband	5q31	PCDHGA4 PCDHB5 PCDHB13 PCDHB9 PCDHB8 PCDHB18P	3.73e-06	115	163	6	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHGA4 PCDHB5 PCDHB13 PCDHB9 PCDHB8 PCDHB18P PCDH1	1.02e-04	298	163	7	chr5q31
GeneFamily	Clustered protocadherins	PCDHGA4 PCDHB5 PCDHB13 PCDHB9 PCDHB8 PCDHB18P	3.56e-06	64	117	6	20
GeneFamily	Non-clustered protocadherins	PCDH11Y PCDH11X PCDH1	5.57e-05	12	117	3	21
GeneFamily	Cadherin related	FAT4 FAT1 FAT2	1.68e-04	17	117	3	24
GeneFamily	CD molecules\|V-set domain containing\|Immunoglobulin like domain containing\|Carcinoembryonic antigen related cell adhesion molecule family	CEACAM5 CEACAM6 CEACAM1	4.84e-04	24	117	3	906
GeneFamily	Cyclins	CCNY CCNYL1 CCNA1	7.69e-04	28	117	3	473
GeneFamily	Immunoglobulin like domain containing	SEMA4D CEACAM5 CEACAM6 IL18BP CEACAM1 ADGRF5	1.61e-03	193	117	6	594
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	NTRK2 ROR2 ROS1	2.19e-03	40	117	3	321
GeneFamily	THAP domain containing	THAP5 THAP3	2.63e-03	12	117	2	65
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	DPP4 SEMA4D CEACAM5 CEACAM6 CEACAM1 KLRK1 PTPRJ CD226	4.11e-03	394	117	8	471
GeneFamily	ATPase phospholipid transporting	ATP9A ATP8B2	4.13e-03	15	117	2	1210
GeneFamily	Adenosine receptors\|V-set domain containing	CEACAM5 CEACAM6 CEACAM1 CD226 VCAN	4.17e-03	163	117	5	590
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 FRAS1 APOB COL24A1 FREM2 FAT1 PCDH11X ROS1 ST18 HYDIN	1.64e-09	184	163	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 FRAS1 APOB COL24A1 FREM2 FAT1 PCDH11X ROS1 ST18 HYDIN	1.64e-09	184	163	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 FRAS1 APOB COL24A1 FREM2 FAT1 PCDH11X ROS1 ST18 HYDIN	1.64e-09	184	163	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C FAT4 ZEB1 ENPP1 PCDH11Y COL24A1 PRELP VCAN PCDH11X BICC1	3.67e-09	200	163	10	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ZEB1 SMCHD1 ETS2 OAS3 PARP14 CCNY ITIH5 TGFBR2 ADGRF5 DYNC1H1	3.67e-09	200	163	10	89821a264e872ed53e08e9d3609d5cc5c314503e
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DPP4 ZEB1 ENPP1 KLRK1 SYNJ2 MLC1 CD226 SAMD3 MYBL1	1.31e-08	169	163	9	e9c0e0f4c421c7bdbf1a7e33002f3cf22ea307cb
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DPP4 ZEB1 ENPP1 KLRK1 SYNJ2 MLC1 CD226 SAMD3 MYBL1	1.31e-08	169	163	9	d375a1df1ecc938f66bad92e54b8cda26ca9c472
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DPP4 ZEB1 ENPP1 KLRK1 SYNJ2 MLC1 CD226 SAMD3 MYBL1	1.31e-08	169	163	9	58f805c0be507bd5fadc9ea3555032daabbc8ab8
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C FAT4 ENPP1 NTRK2 ROR2 COL24A1 PRELP VCAN BICC1	5.37e-08	199	163	9	abd6117f8a3d7e798d8471c16d97b34aaf50fc9c
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ZEB1 SMCHD1 ETS2 OAS3 PARP14 CCNY ITIH5 TGFBR2 ADGRF5	5.61e-08	200	163	9	bcd1cc96197929d6011903803b6f4ccdcf52b4ce
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ZEB1 SMCHD1 ETS2 PARP14 CCNY ITIH5 TGFBR2 ADGRF5 DYNC1H1	5.61e-08	200	163	9	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C FAT4 ZEB1 ENPP1 PRELP VCAN C3 C7 BICC1	5.61e-08	200	163	9	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C FAT4 ROR2 RFX8 ITIH5 COL24A1 VCAN SLITRK6 BICC1	5.61e-08	200	163	9	fb53be20392a8309a7393774c774a1b1aec6e676
ToppCell	Control_saline-Endothelial-Endothelial-Activated_Alv_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	ZEB1 SMCHD1 ETS2 OAS3 PARP14 ITIH5 TGFBR2 ADGRF5 DYNC1H1	5.61e-08	200	163	9	be55cef682ba87250dad97689332c8820b3a7420
ToppCell	facs-Marrow-KLS-18m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TM7SF3 KLRK1 KCNH6 FAT1 PTPRB SORCS2 SAMD3 BICC1	1.04e-07	154	163	8	37765512dfae557b9f6eb30a29463b93682a4404
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1C FRAS1 FREM2 PPP2R2B ROS1 LRRC7 ST18 HYDIN	1.54e-07	162	163	8	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DTL ADGRB2 ITIH5 COL24A1 PRELP VCAN SLITRK6 BICC1	2.13e-07	169	163	8	335619507857383c3b0b507cdf05d786ed59e585
ToppCell	Control-T/NK-NK\|Control / Disease group,lineage and cell class （2021.01.30）	ZEB1 ENPP1 KLRK1 SYNJ2 MLC1 CD226 SAMD3 MYBL1	3.16e-07	178	163	8	079fd19bdeed86bf985c4083af432432d66ad546
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 POLA1 DTL RFX8 CEACAM1 TGFBR2 PTPRB ADGRF5	4.06e-07	184	163	8	688428103e8b19f45f2f65d70a0f30c904c8411c
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	CACNA1C FAT4 ZEB1 ROR2 ITIH5 COL24A1 C7 BICC1	4.59e-07	187	163	8	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C ZEB1 PCDH11Y CCNY CEACAM1 TGFBR2 PTPRB ADGRF5	5.61e-07	192	163	8	27ff3621e177e7932dd44dd6baa81551ea75a874
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C ZEB1 ROR2 RFX8 COL24A1 FAT1 PRELP BICC1	5.84e-07	193	163	8	5de87fc94a6e58899ef4124cf4887ed3ff96163a
ToppCell	RA\|World / Chamber and Cluster_Paper	FRAS1 NTRK2 ROR2 COL24A1 FAT1 PRELP VCAN C7	6.07e-07	194	163	8	08f0afbb68a63150fbe107a5337299081c3f69e4
ToppCell	COVID-19-kidney-PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	CACNA1C ZEB1 SMCHD1 ETS2 CEACAM1 TGFBR2 PTPRB ADGRF5	6.31e-07	195	163	8	a436483fec137584611f86b7a498a4dc2aa19cd3
ToppCell	ASK454-Endothelial-Endothelium\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	DOCK1 FAT4 ENPP1 TGFBR2 PTPRB ADGRF5 C7 PCDH1	6.56e-07	196	163	8	2b777a2026b56839112fd179f2db482c49f4594a
ToppCell	AT2_cells-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	DPP4 CEACAM6 ATP9A CEACAM1 FAT1 C3 ADGRF5 ROS1	6.81e-07	197	163	8	5e0d222872a25bb9e9069d3dffda2844bb69874a
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C FAT4 ZEB1 ROR2 ITIH5 COL24A1 VCAN BICC1	6.81e-07	197	163	8	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNA1C FAT4 ITIH5 COL24A1 VCAN C7 CDH4 BICC1	6.81e-07	197	163	8	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C FAT4 ROR2 ITIH5 COL24A1 PRELP AGT C7	7.08e-07	198	163	8	300d7cc56207d77168390fa1ffcbcf76767b1b80
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNA1C FAT4 ROR2 ITIH5 COL24A1 VCAN C7 BICC1	7.08e-07	198	163	8	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	Fetal_29-31_weeks\|World / Lineage, Cell type, age group and donor	CACNA1C FAT4 FRAS1 ROR2 ATP9A MBOAT2 CTNNA3 BICC1	7.35e-07	199	163	8	5b9d355795dd03a22f0961dfd143425c367a4654
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	POLA1 ZGRF1 DTL STIL ANOS1 STS SYT8 MYBL1	7.35e-07	199	163	8	1d5a3366474c17e3df0ba5cf11b586655529e9bd
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C FAT4 ZEB1 PRELP VCAN C3 C7 BICC1	7.64e-07	200	163	8	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ZEB1 DTL ETS2 CCNY ITIH5 TGFBR2 PTPRB ADGRF5	7.64e-07	200	163	8	58a7ece7dfdf6c46f2a50cbcb580574dec14c748
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C FAT4 ZEB1 ITIH5 VCAN C3 C7 BICC1	7.64e-07	200	163	8	3dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ZEB1 DTL ETS2 CCNY ITIH5 TGFBR2 PTPRB ADGRF5	7.64e-07	200	163	8	b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 POLA1 ETS2 RFX8 CEACAM1 PTPRB ADGRF5	1.78e-06	156	163	7	f894fac4e44a23718b20ad80c9677bf4f2118002
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C ROR2 PCDHB13 COL24A1 AGT C7 BICC1	1.86e-06	157	163	7	f147e24f2ece82e1c54750868954d09b3c461804
ToppCell	343B-Epithelial_cells-Epithelial-H_(AT1)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	APOB ANOS1 FAT1 FAT2 SYT8 PROM2 CCNA1	1.86e-06	157	163	7	dd08dc19d434e94a194076c462ee273c682abf55
ToppCell	343B-Epithelial_cells-Epithelial-H_(AT1)\|343B / Donor, Lineage, Cell class and subclass (all cells)	APOB ANOS1 FAT1 FAT2 SYT8 PROM2 CCNA1	1.86e-06	157	163	7	70fd6c46db4250c7de5c4686a9500689402737f6
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ZEB1 ENPP1 KLRK1 SYNJ2 MLC1 CD226 MYBL1	2.80e-06	167	163	7	94642b3dae035fedb6e8b9745f440096a4539f3c
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ZEB1 ENPP1 KLRK1 SYNJ2 MLC1 CD226 MYBL1	2.80e-06	167	163	7	42b299273a6c72a625b204d55f4f3c4eebd6d185
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ZEB1 ENPP1 KLRK1 SYNJ2 MLC1 CD226 MYBL1	2.80e-06	167	163	7	ecf5bc634e1e01efd783617eb81d1704e903ea21
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CEACAM5 MUC16 FBXO16 STS PROM2 PGBD5	2.91e-06	108	163	6	9c7f3e25facfb54ef0be45044999bc36438bbea0
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CEACAM5 MUC16 FBXO16 STS PROM2 PGBD5	2.91e-06	108	163	6	75d635fc5bb004418db2e1328c24d96b718f10b1
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C FAT4 ZEB1 ROR2 COL24A1 SLITRK6 BICC1	3.54e-06	173	163	7	1f16d47f5548e257e4b17f8070c5619780a9c5fd
ToppCell	(6)_Endothelial_cells-(6)_Endothelial-E\|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	ENPP1 NTRK2 PARP14 TGFBR2 PTPRB ADGRF5 SAMD3	3.68e-06	174	163	7	4a1b67ce5ea353b3f81f59fa57da07668146afca
ToppCell	CTRL-Lymphoid-T_cell_&_NK_cell\|CTRL / Disease state, Lineage and Cell class	DPP4 ZEB1 ATP8B2 PPP2R2B CD226 SAMD3 MYBL1	4.11e-06	177	163	7	e73d8e78a96b63e27a8a7694c62b3c44ec7ecfe6
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C FAT4 ZEB1 ROR2 COL24A1 PRELP SLITRK6	4.60e-06	180	163	7	01f2e5d96016823482f89ba503d007d4bd88eeac
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP KCNH6 FAT1 VCAN SORCS2 TXNDC16 BICC1	4.77e-06	181	163	7	e4c3e0eae9f21e78b5dd18cf017bd041ffc8c968
ToppCell	NS-moderate-d_0-4-Lymphoid-CTL\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ZEB1 DOCK11 DTL KLRK1 CD226 SAMD3 MYBL1	4.77e-06	181	163	7	7fb3c1d29c542a3cea7fa654432d501d82df138f
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP KCNH6 FAT1 VCAN SORCS2 TXNDC16 BICC1	4.77e-06	181	163	7	35eefd874a892eaf21f24fdce89e7ea3b8ee285f
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C ZEB1 ROR2 ETS2 COL24A1 FAT1 VCAN	4.94e-06	182	163	7	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	Control-T_cells-NK_cells\|Control / group, cell type (main and fine annotations)	SEMA4D KLRK1 PPP2R2B MLC1 CD226 SAMD3 MYBL1	5.50e-06	185	163	7	755c0998c729f462399f1d5e88adf4bfae31be30
ToppCell	Control-T_cells\|Control / group, cell type (main and fine annotations)	SEMA4D SMCHD1 KLRK1 PPP2R2B CD226 SAMD3 MYBL1	5.90e-06	187	163	7	f4e8e0eba58da89b56587667555a5d4754e108c7
ToppCell	ILEUM-inflamed-(1)_Cytotoxic_CD8_Trm\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	DPP4 CREM KLRK1 CD226 NFE2L2 SAMD3 MYBL1	6.11e-06	188	163	7	d26894d1066a70e4b32ae41fff1c4718f2591ba9
ToppCell	(2)_Fibroblasts-(20)_Fibro-1\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	DPP4 NTRK2 ITIH5 PPP2R2B VCAN C3 BICC1	6.11e-06	188	163	7	409a7b69d02e87084ca955e3fe6c77230dee8861
ToppCell	COVID-19-Epithelial-Ionocytes\|COVID-19 / Condition, Lineage and Cell class	RAP1GAP MUC16 ITIH5 FREM2 FAT1 PROM2 ADGRF5	6.11e-06	188	163	7	a581cb9528d0febbf3addbb4f6bc140f91a584e6
ToppCell	Mesenchymal-myofibroblast_cell\|World / Lineage, Cell type, age group and donor	CACNA1C FAT4 ZEB1 ROR2 COL24A1 FAT1 SLITRK6	6.33e-06	189	163	7	44e37f88137bb249933eb615235b2cf2ae7f3925
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D231\|Adult / Lineage, Cell type, age group and donor	DPP4 PGC FREM2 SORCS2 C3 ADGRF5 ROS1	6.33e-06	189	163	7	dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCell	COVID-19-T_cells-NK_cells\|COVID-19 / group, cell type (main and fine annotations)	SEMA4D KLRK1 PPP2R2B MLC1 CD226 SAMD3 MYBL1	6.33e-06	189	163	7	b699152dfbb8cd8ed724e1e5a51838f29b681b62
ToppCell	facs-GAT-Fat-24m-Mesenchymal\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITIH5 PRELP AGT C3 C7 MNDA BICC1	6.55e-06	190	163	7	3720e64129f3f3268b1dc14031a76f41c38241c2
ToppCell	facs-GAT-Fat-24m-Mesenchymal-mesenchymal_progenitor\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITIH5 PRELP AGT C3 C7 MNDA BICC1	6.55e-06	190	163	7	73a50426f972f08f9bb525ad5c0b774187ab5d6a
ToppCell	facs-GAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITIH5 PRELP AGT C3 C7 MNDA BICC1	6.55e-06	190	163	7	b55cf1fb586b724295b7b038483249847bb344fc
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ZEB1 ZGRF1 DTL STIL PTPRB SORCS2 LRRC7	6.55e-06	190	163	7	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	COVID-19-T_cells\|COVID-19 / group, cell type (main and fine annotations)	SEMA4D SMCHD1 KLRK1 PPP2R2B CD226 SAMD3 MYBL1	6.78e-06	191	163	7	7f64add931b64b8d35836fa6bee9ebab593844d3
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPP4 ITIH5 PRELP VCAN C3 C7 MNDA	7.02e-06	192	163	7	11088878043a6ff95ba1970361256a82e434b80a
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NTRK2 ITIH5 PRELP C3 MNDA BICC1 CRTAP	7.02e-06	192	163	7	fc940f91ff8e051631dbf25e6e8d73cf8337eccb
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPP4 NTRK2 ITIH5 TGFBR2 VCAN C3 MNDA	7.02e-06	192	163	7	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	facs-Trachea-24m-Mesenchymal\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NTRK2 ITIH5 PRELP C3 MNDA BICC1 CRTAP	7.02e-06	192	163	7	e8af6ad1ae99cae13a82d0d8d7f38af9b777f0ba
ToppCell	NS-moderate-d_07-13-Lymphoid-CTL\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SEMA4D ATP8B2 KLRK1 PPP2R2B CD226 SAMD3 MYBL1	7.02e-06	192	163	7	ab2c3d829f5cbf4eb386babcfdf851222a2a88e8
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C ZEB1 ROR2 RFX8 COL24A1 FAT1 BICC1	7.02e-06	192	163	7	67e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NTRK2 ITIH5 PRELP C3 MNDA BICC1 CRTAP	7.02e-06	192	163	7	7a2e79490e4f7058bb76b46c45b5df9f729e3146
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1\|TCGA-Endometrium / Sample_Type by Project: Shred V9	FRAS1 POLA1 DTL TUBGCP4 SMYD2 FREM2 SLITRK6	7.26e-06	193	163	7	c2673d86f7d7b849788036032a93a6d136a70040
ToppCell	Adult-Immune-T_lymphocyte\|Adult / Lineage, Cell type, age group and donor	SEMA4D ZEB1 ATP8B2 PPP2R2B CD226 SAMD3 MYBL1	7.26e-06	193	163	7	26df0c4c8a2355dd5503fadd07e368eb9a2bf06a
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NTRK2 ITIH5 PRELP VCAN C3 BICC1 CRTAP	7.26e-06	193	163	7	25248b8e65d558b1a96a87c93e3e5b4c0ba168fe
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SEMA4D ZEB1 ATP8B2 PPP2R2B CD226 SAMD3 MYBL1	7.26e-06	193	163	7	b9769b45125d2244afe53f9f71c92c04ddccf980
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NTRK2 ITIH5 VCAN C3 C7 MNDA BICC1	7.26e-06	193	163	7	160691b671710be10220803d788c2c961c236af1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FAT4 ZEB1 ETS2 CEACAM1 TGFBR2 PTPRB ADGRF5	7.26e-06	193	163	7	456aa8a8f1f9cbba0bd618a5f623909079c0f56b
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NTRK2 ITIH5 PRELP VCAN C3 BICC1 CRTAP	7.26e-06	193	163	7	f1f1097204e07a7bed416425b8256942038a734f
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	CACNA1C ZEB1 ETS2 CCNY CEACAM1 PTPRB ADGRF5	7.26e-06	193	163	7	479abb1cd2eb978b8a4fdb900069a6329fc8cade
ToppCell	Adult-Immune-T_lymphocyte-D231\|Adult / Lineage, Cell type, age group and donor	SEMA4D ZEB1 ATP8B2 PPP2R2B CD226 SAMD3 MYBL1	7.51e-06	194	163	7	5c1dca33f382f37a7deb23e573578343c3b54986
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	CACNA1C ROR2 RFX8 COL24A1 VCAN C7 BICC1	7.51e-06	194	163	7	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SEMA4D ZEB1 SMCHD1 ATP8B2 CD226 SAMD3 MYBL1	7.51e-06	194	163	7	3d6f2d190dd50804afea299957cc44c2bb756134
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NTRK2 PRELP C3 C7 MNDA BICC1 CRTAP	7.51e-06	194	163	7	889c6e231bdd5b59902c7d2afdc077360b1d3256
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KLRK1 PPP2R2B MLC1 CD226 SAMD3 PCDH1 MYBL1	7.76e-06	195	163	7	98b02beafe1d418442e41f85cbf0c7b194fe5957
ToppCell	facs-Heart-LA-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZEB1 ENPP1 PRELP VCAN C3 C7 BICC1	7.76e-06	195	163	7	79a6e8e6de040ff07539e8901fc407363a50e355
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT4 ATP8B2 PRELP VCAN C3 C7 BICC1	7.76e-06	195	163	7	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KLRK1 PPP2R2B MLC1 CD226 SAMD3 PCDH1 MYBL1	7.76e-06	195	163	7	9ecae6c26a0d0607d101ccf1c38f0b23c5a256a8
ToppCell	facs-Trachea-18m-Mesenchymal\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NTRK2 ITIH5 PRELP VCAN C3 BICC1 CRTAP	7.76e-06	195	163	7	0d1876f6fdc1eafeb60d6fd7da5bce737d2b4a5a
ToppCell	COVID-19-kidney-VWF+PLVAP+VCAM1+EC\|kidney / Disease (COVID-19 only), tissue and cell type	CACNA1C ZEB1 ETS2 CEACAM1 TGFBR2 PTPRB ADGRF5	8.03e-06	196	163	7	ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42
ToppCell	PCW_07-8.5-Mesenchymal\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CACNA1C ROR2 COL24A1 VCAN C7 SLITRK6 BICC1	8.03e-06	196	163	7	8e10802f52e5e1853ea4ad34bf9a32a34e6112b5
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KLRK1 PPP2R2B MLC1 CD226 SAMD3 PCDH1 MYBL1	8.03e-06	196	163	7	9b3848dd4256cd6d9a21ef6bfdbd0cb7c0030005
ToppCell	COVID-19-lung-Proliferative_fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	CACNA1C ZGRF1 ROR2 DTL STIL RFX8 BICC1	8.03e-06	196	163	7	2ce8a787f2731faa913d20342d73041d59468f27
ToppCell	Basal_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	FRAS1 FAT1 FAT2 CELSR2 SYT8 PROM2 SLITRK6	8.03e-06	196	163	7	3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA4D FRAS1 FREM2 FAT1 PTPRJ HYDIN BICC1	8.03e-06	196	163	7	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	C_05\|World / shred on cell type and cluster	CEACAM5 CEACAM6 OAS3 PPP1R14D PARP14 CEACAM1 TM4SF20	8.03e-06	196	163	7	bf4dfb460a153dbafb2b9b12b360c8757cec22cd
ToppCell	Basal_cells\|World / lung cells shred on cell class, cell subclass, sample id	FRAS1 FAT1 FAT2 CELSR2 SYT8 PROM2 SLITRK6	8.30e-06	197	163	7	24360b660000bdfb999d58fbf4e29585a97e1785
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SEMA4D KLRK1 PPP2R2B MLC1 CD226 SAMD3 MYBL1	8.30e-06	197	163	7	32b770e403028862f91e4727f4a8fbb6151910e4
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FRAS1 ETS2 MUC16 ANOS1 FAT2 SYT8 PROM2	8.30e-06	197	163	7	107cb153ea7fc74bbd244dbb9d0499c0a8506724
Disease	Cryptophthalmos syndrome	FRAS1 FREM2	8.41e-05	3	157	2	C0265233
Disease	FRASER SYNDROME 1	FRAS1 FREM2	8.41e-05	3	157	2	C4551480
Disease	Malignant neoplasm of salivary gland	DTL FAT1 MLC1 VCAN	9.70e-05	45	157	4	C0220636
Disease	Salivary Gland Neoplasms	DTL FAT1 MLC1 VCAN	1.15e-04	47	157	4	C0036095
Disease	hydrocephalus (implicated_via_orthology)	CELSR2 NME7 HYDIN	1.35e-04	19	157	3	DOID:10908 (implicated_via_orthology)
Disease	Squamous cell carcinoma of esophagus	FAT4 TGFBR2 FAT1 FAT2 NFE2L2	1.58e-04	95	157	5	C0279626
Disease	Fraser syndrome (implicated_via_orthology)	FRAS1 FREM2	1.68e-04	4	157	2	DOID:0090001 (implicated_via_orthology)
Disease	Hepatomegaly	COPS3 MBOAT2 MLC1 NFE2L2	1.98e-04	54	157	4	C0019209
Disease	Adenoid Cystic Carcinoma	DTL FAT1 MLC1 VCAN MYBL1	2.00e-04	100	157	5	C0010606
Disease	Aneurysm, Dissecting	TGFBR2 AGT	2.78e-04	5	157	2	C0002949
Disease	Dissection of aorta	TGFBR2 AGT	2.78e-04	5	157	2	C0340643
Disease	Dissection, Blood Vessel	TGFBR2 AGT	2.78e-04	5	157	2	C4277533
Disease	Cardiac Arrhythmia	CACNA1C AGT CTNNA3	3.12e-04	25	157	3	C0003811
Disease	response to gemcitabine	DOCK1 CACNA1C ITIH5	3.12e-04	25	157	3	GO_0036272
Disease	pneumonia, COVID-19	CHRAC1 FAT1 ST18 CDH4 VPS13B	3.54e-04	113	157	5	EFO_0003106, MONDO_0100096
Disease	LDL cholesterol change measurement	APOB CELSR2	5.80e-04	7	157	2	EFO_0007804
Disease	regulator of G-protein signaling 8 measurement	C3 C7	5.80e-04	7	157	2	EFO_0801997
Disease	Aortic Aneurysm	TGFBR2 AGT	5.80e-04	7	157	2	C0003486
Disease	Alzheimer's disease (is_implicated_in)	NTRK2 PPP2R2B NFE2L2 C3 UQCRC1	7.19e-04	132	157	5	DOID:10652 (is_implicated_in)
Disease	esterified cholesterol measurement, intermediate density lipoprotein measurement	APOB CELSR2	7.71e-04	8	157	2	EFO_0008589, EFO_0008595
Disease	Unilateral agenesis of kidney	FRAS1 FREM2	7.71e-04	8	157	2	C0266294
Disease	alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement	C3 C7	7.71e-04	8	157	2	EFO_0801373
Disease	Congenital Hydrocephalus	WDR81 HYDIN	7.71e-04	8	157	2	C0020256
Disease	carbonic anhydrase-related protein 10 measurement	CELSR2 C7	7.71e-04	8	157	2	EFO_0020233
Disease	acoustic startle blink response measurement	CACNA1C PARP14	9.88e-04	9	157	2	EFO_0006875
Disease	cellular retinoic acid-binding protein 1 measurement	C3 C7	9.88e-04	9	157	2	EFO_0801463
Disease	SPINOCEREBELLAR ATAXIA 17	HYOU1 ATP5F1B	9.88e-04	9	157	2	C1846707
Disease	RNA-binding protein 24 measurement	C3 C7	9.88e-04	9	157	2	EFO_0802030
Disease	beverage consumption measurement	DOCK1 HIVEP1 NTRK2 PCDH1	1.02e-03	83	157	4	EFO_0010088
Disease	Anemia, Sickle Cell	CACNA1C NFE2L2	1.23e-03	10	157	2	C0002895
Disease	DNA-directed RNA polymerases I and III subunit RPAC1 measurement	C3 C7	1.23e-03	10	157	2	EFO_0801535
Disease	unipolar depression, age at onset	ETS2 FAT1 SAMD3	1.26e-03	40	157	3	EFO_0003761, EFO_0004847
Disease	Nodular glomerulosclerosis	TGFBR2 NFE2L2 AGT	1.36e-03	41	157	3	C0017667
Disease	Proteinuria	DPP4 MUC16 AGT	1.56e-03	43	157	3	C0033687
Disease	Diabetic Nephropathy	TGFBR2 NFE2L2 AGT	1.67e-03	44	157	3	C0011881
Disease	pulmonary fibrosis (implicated_via_orthology)	NFE2L2 AGT	1.79e-03	12	157	2	DOID:3770 (implicated_via_orthology)
Disease	oncostatin-M measurement	C3 C7	1.79e-03	12	157	2	EFO_0010792
Disease	tyrosine-protein kinase ZAP-70 measurement	C3 C7	1.79e-03	12	157	2	EFO_0020833
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	KIF28P BICC1	2.45e-03	14	157	2	DOID:898 (implicated_via_orthology)
Disease	thalamus volume change measurement	FAT1 SORCS2	2.45e-03	14	157	2	EFO_0021496
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	APOB CELSR2	2.45e-03	14	157	2	EFO_0004611, EFO_0008589
Disease	polycystic kidney disease (implicated_via_orthology)	STAM2 AGT	2.45e-03	14	157	2	DOID:0080322 (implicated_via_orthology)
Disease	Mental Depression	CACNA1C DPP4 CHRNA6 NTRK2 AGT BICC1	2.46e-03	254	157	6	C0011570
Disease	Early Pregnancy Loss	CEACAM5 CEACAM6 CEACAM1 CD226	2.78e-03	109	157	4	C3830362
Disease	Spontaneous abortion	CEACAM5 CEACAM6 CEACAM1 CD226	2.78e-03	109	157	4	C0000786
Disease	Miscarriage	CEACAM5 CEACAM6 CEACAM1 CD226	2.78e-03	109	157	4	C4552766
Disease	Abortion, Tubal	CEACAM5 CEACAM6 CEACAM1 CD226	2.78e-03	109	157	4	C0000822
Disease	response to olanzapine	CACNA1C HIVEP1	2.82e-03	15	157	2	GO_0097333
Disease	Hypertriglyceridemia	APOB CELSR2	2.82e-03	15	157	2	C0020557
Disease	response to statin, LDL cholesterol change measurement	APOB CELSR2	2.82e-03	15	157	2	EFO_0007804, GO_0036273
Disease	free cholesterol measurement	APOB CELSR2 CLPTM1 NUP160	3.17e-03	113	157	4	EFO_0008591
Disease	congenital myasthenic syndrome (implicated_via_orthology)	CHRNA6 SYT8	3.21e-03	16	157	2	DOID:3635 (implicated_via_orthology)
Disease	nervousness	PTPRJ NUP160	3.21e-03	16	157	2	NCIT_C74532
Disease	diabetic retinopathy (implicated_via_orthology)	NFE2L2 AGT	3.21e-03	16	157	2	DOID:8947 (implicated_via_orthology)
Disease	sickle cell anemia (is_implicated_in)	APOB C3	3.21e-03	16	157	2	DOID:10923 (is_implicated_in)
Disease	MAJOR AFFECTIVE DISORDER 2	MLC1 GPRC5D	3.63e-03	17	157	2	C1839839
Disease	Antibody Deficiency Syndrome	CACNA1C C3	3.63e-03	17	157	2	C0003257
Disease	IGF-1 measurement, IGFBP-3 measurement	CELSR2 SORCS2	3.63e-03	17	157	2	EFO_0004626, EFO_0004627
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	APOB CELSR2	3.63e-03	17	157	2	EFO_0022232
Disease	visfatin measurement	PLB1 PCDH1	3.63e-03	17	157	2	EFO_0801230
Disease	Hypertrophy	CREM AGT	4.07e-03	18	157	2	C0020564
Disease	very low density lipoprotein cholesterol measurement, esterified cholesterol measurement	APOB CELSR2	4.07e-03	18	157	2	EFO_0008317, EFO_0008589
Disease	bipolar disorder (is_marker_for)	RAP1GAP NTRK2	4.53e-03	19	157	2	DOID:3312 (is_marker_for)
Disease	DiGeorge syndrome (implicated_via_orthology)	DOCK1 TGFBR2	4.53e-03	19	157	2	DOID:11198 (implicated_via_orthology)
Disease	sodium-coupled monocarboxylate transporter 1 measurement	APOB CELSR2	4.53e-03	19	157	2	EFO_0802076
Disease	Depressive disorder	CACNA1C DPP4 CHRNA6 NTRK2 AGT BICC1	4.62e-03	289	157	6	C0011581
Disease	coronary artery disease, plasminogen activator inhibitor 1 measurement	APOB CELSR2 NME7	4.65e-03	63	157	3	EFO_0001645, EFO_0004792
Disease	esterified cholesterol measurement	APOB CELSR2 CLPTM1 NUP160	4.94e-03	128	157	4	EFO_0008589
Disease	serum carcinoembryonic antigen measurement	CEACAM5 CEACAM6	5.02e-03	20	157	2	EFO_0005760
Disease	choline measurement	PLB1 APOB CELSR2 BICC1	5.22e-03	130	157	4	EFO_0010116

Protein segments in the cluster

Peptide	Gene	Start	Entry
VPSADDVQRFFQVVS	ADGRB2	656	O60241
IENVTSIANNFPDFS	C21orf62	186	Q9NYP8
FEITNQSFNIVDIKP	PPP2R2B	201	Q00005
NDQATVNPVEFNTEV	VCAN	3041	P13611
VPDFETLFSQVQLFI	COPS3	71	Q9UNS2
ELIQTIDNIVFFPAT	ARFGEF1	1626	Q9Y6D6
TFQQSTQELFIPNIT	CEACAM5	276	P06731
NVIVDDVNDNVPTFA	FAT4	2351	Q6V0I7
TVNVIDVNDNSPVFL	FAT4	3181	Q6V0I7
ENSPQQVFSTEFEVK	C3	211	P01024
SRVLQQLQVFTFFPE	DNMBP	1226	Q6XZF7
VPTLLQAFFSAVTQV	AP5Z1	556	O43299
FLELLQFNINVPSSV	CCNY	256	Q8ND76
VTVQVLDINDNAPIF	CELSR2	491	Q9HCU4
VSVTVLDVNDNNPTF	CELSR2	596	Q9HCU4
PSVDFQQSVTVVLFQ	DTL	211	Q9NZJ0
TDVFQQQEIDLQTFL	BICC1	891	Q9H694
FLELLQFNINVPASV	CCNYL1	276	Q8N7R7
TSAEVQLPQFLAQVD	DANCR	121	P0C864
QRFLSQPFQVAEVFT	ATP5F1B	461	P06576
LVPDGIAQSQVFEFT	ARHGEF9	481	O43307
IQDNFSVTQVPFTES	AGT	316	P01019
LTFLPVNLFEQFQEV	ATP8B2	61	P98198
AENFIQSIISTVEPA	PGM1	36	P36871
ENPVQFFQTDLQLTD	PCDHB5	111	Q9Y5E4
TDDPNFQVVIFVFLL	OR6C1	16	Q96RD1
RFLQVFVQPANVAVT	ARHGAP39	1016	Q9C0H5
VLVSDVNDNAPIFTQ	PCDHB18P	386	Q96TA0
EQFIAQVQTNLDIFT	OVOS1	261	Q6IE37
FFIEIASPFSVVQNE	OVOS1	681	Q6IE37
ASPFSVVQNEQFDLI	OVOS1	686	Q6IE37
IILVDTNDNAPVFTQ	PCDHGA4	261	Q9Y5G9
FNTGVINVIAPLDFE	FAT1	2231	Q14517
VNVNVTDINDNTPVF	FAT1	3321	Q14517
PENLSASFIVQDVNI	ANOS1	551	P23352
VSEEPFTLNFTINNL	MUC16	13921	Q8WXI7
LESPFEFFQAELQVI	PCDHB13	111	Q9Y5F0
QVDPLVQSFSFQNLL	PTPRB	1131	P23467
QPQAIEFRTNAIQVF	PTPRJ	356	Q12913
SQNPNVQEIVFVVFL	OR4C15	16	Q8NGM1
NRFTQVFVDPLTVID	MDN1	1886	Q9NU22
ISDQQFFSEPQLINI	FRAS1	1196	Q86XX4
FFSEPQLINIQAFST	FRAS1	1201	Q86XX4
FQAVIAINDTFQDVP	FRAS1	2901	Q86XX4
SNAVQLPIDQVNFVV	MBOAT2	16	Q6ZWT7
NETFANIIFKPTVVQ	ITIH5	231	Q86UX2
ALVENVSTEFQSPQV	FSCB	751	Q5H9T9
FSFSQPSVNEDAVVN	LRRC7	1086	Q96NW7
PQVSVVFIFVNEALS	GALNT9	151	Q9HCQ5
TNFSCVLVDPEQVVQ	IL18BP	146	O95998
TFQQSTQELFIPNIT	CEACAM6	276	P40199
FQQVSDPVAAEFSLN	FREM2	2846	Q5SZK8
RTISQIPQFTLNFVE	KCNH6	176	Q9H252
DVVNSVVFSPQEQEL	FBXW5	511	Q969U6
TVEIFVLDVNDNSPQ	FAT2	2996	Q9NYQ8
KAVAENFFVETLQPQ	FHIP2B	366	Q86V87
VVDVNDNAPVFTQSV	PCDH1	496	Q08174
DNAPVFTQSVTEVAF	PCDH1	501	Q08174
FTQSVTEVAFPENNK	PCDH1	506	Q08174
EENTIFAPRIQFFAI	PBDC1	131	Q9BVG4
QLLAQTFPFVDDNEV	NFE2L2	121	Q16236
AVFLNSLFNQEVQIP	KLRK1	76	P26718
LFAVFPSLNEEQTLQ	ETS2	36	P15036
TLPVTVTFFDVSEQN	FAM214B	386	Q7L5A3
AVNPTVKFFVVNTDS	DPP4	261	P27487
QQPLFSLVDFEQVVD	TUBGCP4	316	Q9UGJ1
SILPIEDFQTQFNLT	ENPP1	631	P22413
DQILNFTILQIFPFT	ATP9A	531	O75110
DNAPVFTQSFVTVSI	PCDH11X	461	Q9BZA7
VFVSIIDQNDNSPVF	PCDH11X	556	Q9BZA7
FIEIASPFSVVQNEQ	OVOS2	781	Q6IE36
SPFSVVQNEQFDLIV	OVOS2	786	Q6IE36
LQAVFTNFPVLIQFV	OC90	66	Q02509
TDNPQLQVVIFSFLF	OR6C76	16	A6NM76
ATFAQALQFVPETQV	UQCRC1	36	P31930
ALQFVPETQVSLLDN	UQCRC1	41	P31930
PSIIQEFNICFTTVQ	POLA1	866	P09884
FFIAIPGQVTEQQQL	NEU2	101	Q9Y3R4
IQVSPEIFQFLQQVN	PARP14	536	Q460N5
SAVDFFQLFVPDNVL	PGBD5	121	Q8N414
VNFLTSTVIPEFVTQ	CTNNA3	571	Q9UI47
TQFLEAAQQEFNLPV	GMPPA	66	Q96IJ6
SPEVEDVINSVQFIA	CHRNA6	426	Q15825
FEITVPESQLTVSQF	APOB	3811	P04114
FQISSQLQFSPEEVL	HYOU1	136	Q9Y4L1
TFNQSILFTIPELQE	HYDIN	4451	Q4G0P3
QFAQDPKFIEVTTQE	CACNA1C	2131	Q13936
TNVEPFFINLALFDV	DOCK11	391	Q5JSL3
FQPVAGENDFLQTVI	DOCK1	351	Q14185
LAFAFIIELNQQTAP	GPRC5D	76	Q9NZD1
TFQQSTQELFIPNIT	CEACAM1	276	P13688
NAVFVENFQRDPTLT	CACNA2D4	231	Q7Z3S7
PEAVQFFNVTTLQKE	CRTAP	356	O75718
AFDLTVPTTNQFLLQ	CCNA1	336	P78396
TVEVAQFINNNPEFL	C7	256	P10643
FATRELQVPSEQVAF	CDH4	86	P55283
NVLFSTQDPVEDAVF	DENND4C	1006	Q5VZ89
FNPAFFQTTVTAQIL	EIF3K	56	Q9UBQ5
IVLFFLPSDVTQNSE	MS4A14	156	Q96JA4
LIFPVVQQFTEAFVQ	IPO9	236	Q96P70
VQQFTEAFVQALQIP	IPO9	241	Q96P70
NFIPTIVNFSAEEIS	DYNC1H1	3346	Q14204
FIVFIAPTDQGTQTE	MPP1	396	Q00013
FVIADVQLVTSNSPE	FBXO16	176	Q8IX29
VIQVVQSDSFEAAVP	CD226	121	Q15762
VANSQDQVLEAEPQF	METTL13	186	Q8N6R0
QFFVPGSQVVVQDEE	CREM	221	Q03060
VNPQIEETVQFAALT	KIF28P	746	B7ZC32
VQPTSAFIQQPFIDE	MYBL1	246	P10243
QSRPFFNELIQFITT	NME7	141	Q9Y5B8
PQSAAEQDVVVQETF	PRDM2	1116	Q13029
ENDNAPVFTQSFVTV	PCDH11Y	491	Q9BZA8
VTVFVSIIDQNDNSP	PCDH11Y	586	Q9BZA8
PDSLFSVVIVNLFVN	PCDH11Y	791	Q9BZA8
EQNVPEALQFQLVST	OAS3	521	Q9Y6K5
VDAQVQELFQDQATP	PPP1R14D	76	Q9NXH3
LESPFEFFQAELQVI	PCDHB8	111	Q9UN66
VVLDVNDNVPQFAQA	PCDHB9	231	Q9Y5E1
VSDFNQNFEVPNRII	MNDA	286	P41218
FISNEEPFVVQSCVQ	MINAR1	241	Q9UPX6
SPNVFNETEFSLNVT	RTN3	616	O95197
AFTFLVPFSQVQNVD	SYT8	311	Q8NBV8
AIATCVPNEVNFQDF	TIGD6	406	Q17RP2
SEILVIENGTAFPFQ	SMCHD1	936	A6NHR9
LQADNNFITVIEPSA	SLITRK6	141	Q9H5Y7
FNPEVGIFVSIAQSE	SMG5	786	Q9UPR3
SPEEQFEQQTVHFTI	SYNJ2	1251	O15056
SVALEEQNNVFLSPV	TDRD9	421	Q8NDG6
TSFSVVDNPINIVLQ	SAMD3	371	Q8N6K7
DEAVLFVQVNSPLQA	SORCS2	861	Q96PQ0
DIVAVVFQDENTPFV	RAP1GAP	291	P47736
VDPIVSNFLQSFETA	POLR3A	186	O14802
VEAAQFIQRNTETPF	STS	266	P08842
QVFRIPLTDAQNFSF	TEX49	71	A0A1B0GTD5
NTSEQFETVAVKIFP	TGFBR2	266	P37173
NNFITELPVESFQNA	PRELP	111	P51888
FLNFLEPVNNITIVQ	ROR2	61	Q01974
IEETQLFQDFEPVQT	SEMA4D	461	Q92854
DFAVVVQPFFQNTLT	PLB1	1316	Q6P1J6
FNSQAIAPTIEQIDQ	PHAF1	96	Q9BSU1
VSSPQTIVELFFQEV	NUP160	816	Q12769
VNQDPITQSIFNESV	SPICE1	146	Q8N0Z3
ITQSIFNESVIEPQA	SPICE1	151	Q8N0Z3
VKQIEFNFPSQAITS	ST18	471	O60284
IVSLVEEDQFSQNPI	TM4SF20	31	Q53R12
FQAVTINESNFFVTP	ADGRF5	266	Q8IZF2
INESNFFVTPEIIFE	ADGRF5	271	Q8IZF2
LDNETNFVVQVSVFI	CLPTM1	411	O96005
AQQSETFQFLADILP	CHRAC1	81	Q9NRG0
IPEVQTFDSNSVFTL	COL24A1	191	Q17RW2
NSVDPENITEIFIAN	NTRK2	61	Q16620
TDEQFLVQDQFPVTP	VPS51	546	Q9UID3
SNIAVEEEFNQPLSV	STIL	856	Q15468
PVSFDVQTAQIFFTK	SPRYD3	151	Q8NCJ5
QVFAFPSDQAIIEEN	TXNDC16	701	Q9P2K2
QDQFVDISFPSQVVN	USPL1	646	Q5W0Q7
FQIPVSFQDLTVNFT	ZNF334	6	Q9HCZ1
FIVEALQLPNFQQSV	ELAC2	446	Q9BQ52
DTLTVQSIQVPNQEF	PGC	146	P20142
VSDVPQELQAVAQQF	PROM2	201	Q8N271
VAQQFSLPQEQVSEE	PROM2	211	Q8N271
QQFVIQISDVPQSSE	RFX8	561	Q6ZV50
PFLFSTINQTVEELN	THAP5	251	Q7Z6K1
NVQFLPFLTTEVNNL	SLC50A1	41	Q9BRV3
QFPQLTRSQVFQSEF	NDUFB2	46	O95178
TNLTVEQPVFAANFI	WBP2NL	81	Q6ICG8
EQIFTNVTQVVDFVA	TANGO6	656	Q9C0B7
FPSNFVTTNLNIETE	STAM2	251	O75886
SVLEPARFNQFTIIQ	ROS1	916	P08922
NIFVDPEDQSQVTLA	VRK3	311	Q8IV63
AVATFLQSVQVPEFT	UBA1	786	P22314
VEEFLQQQDTAVIFP	ZEB1	126	P37275
AINFVDEPAPNQVTF	UBR3	616	Q6ZT12
FVVSVSEDTQQQAFP	VPS13B	3896	Q7Z7G8
SNVTQPFLEVTFNLN	ZGRF1	521	Q86YA3
QLTVEFLEENSFSVP	PHF8	146	Q9UPP1
TVLQDFDQPINIISD	ERVK-19	506	Q9WJR5
VFAFQDPTQQVRENT	THAP3	81	Q8WTV1
FPDNDSLVVLFAQVN	SMYD2	166	Q9NRG4
QVFLVPTGEVFEQQV	UHRF1BP1	1386	Q6BDS2
DVFSQPEISNEAVNL	HIVEP1	1816	P15822
LSEPVATFFQVFSQL	WDR81	1421	Q562E7
QDPVAFKDVAVNFTQ	ZNF439	16	Q8NDP4
TNVPFQTNDFIILAV	TM7SF3	476	Q9NS93
TSFQEPFLITNEIVD	TPP1	391	O14773
NVIPNFQILFVSTFA	MLC1	106	Q15049
VAPFISDFTAFQNVV	LEG1	276	Q6P5S2
SFQVLAALVESPVTQ	NADSYN1	66	Q6IA69